REFERENCES

Folia Med Cracov. 2021;61(2):117-127.

Mucormycosis in head and neck area - the emerging health problem in COVID-19 pandemic. The perspective of a dental practitioner

M Pasternak, R Olszanecki

Abstract

Mucormycosis is an invasive fungal disease caused by saprophytic molds and is characterized by a fulminant course and high mortality. Reported increase of disease cases and more frequent mucormycosis superinfections in COVID-19 patients are of a serious concern. Head and neck area is the most typical location of mucormycosis and often the first symptoms are eminent in oral cavity, therefore a dentist may be the first healthcare practitioner to recognize signs of this dangerous and potentially fatal disease. Urgent diagnosis and implementation of appropriate treatment are essential for the patient's survival. The dentist's participation in postoperative care is necessary and due to the destructive nature of radical surgical treatment, prosthetic rehabilitation is required to improve the patient's function and quality of life. Furthermore the vigilance of dentists will also allow early recognition of frequent recurrences of this insidious infection.

Adapted from M Pasternak et al, Folia Med Cracov. 2021;61(2):117-127, for more info about this publication click HERE

References

A Hamilton et al., Clin Oral Implants Res. 2021 Aug 23| S P De Ry, et al., J Periodontol. 2021 Jul 14| T T Zahng et al., Shanghai Kou Qiang Yi Xue. 2021 Jun;30(3):292-296| C Aparicio et al., Int J Oral Maxillofac Implants. Jul-Aug 2021;36(4):807-817| M Emmert et al., J Oral Implantol. 2021 Sep 7| A A Ahamed et al., J Long Term Eff Med Implants.2021;31(3):51-56 | H AlQallaf et al., Compend Contin Educ Dent. Jul-Aug 2021;42(7):f1-f4| C Aparicio et al., Atlas Oral Maxillofac Surg Clin North Am. 2021 Sep;29(2):203-231| L Tran-Hung et al., J Dent Imp Res 2021; 40(3): 59-65| E Schiegnitz et al., Int J Implant Dent. 2021 Jul 13;7(1):93| A W AlQutub, Int J Dent. 2021 Aug 31;2021:4134932| M Pasternak et al, Folia Med Cracov. 2021;61(2):117-127| source: www.pubmed.gov| and Google Scholar Dr Nair holds a position of Global Scientific Communications Manager at Institute Straumann in Basel, Switzerland.